Investigators discuss the use of targeted therapies to treat metastatic colorectal cancer.
Jeremy C. Jones, MD
Advertisement
Articles by Jeremy C. Jones, MD
Patients with colorectal cancer could benefit from the COLMATE platform as it allows for opportunities in clinical trial enrollment.
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on CancerNetwork
1
MYTHIC Trial Demonstrates Efficacy in Platinum-Resistant Ovarian Cancer
2
Novel HP1K Inhibitor Shows Favorable Responses in ccRCC, Solid Tumors
3
FDA Grants RMAT Designation to RZ-001 in Advanced Hepatocellular Carcinoma
4
119 Progression-Free Survival (PFS) and Overall Survival (OS) Results From the Phase 3 MONALEESA-3 Trial of Postmenopausal Patients With Hormone Receptor–Positive (HR+)/Human Epidermal Growth Factor Receptor 2–Negative (HER2−) Advanced Breast Cancer (ABC) Treated With Ribociclib (RIB) + Fulvestrant (FUL): A Subgroup Analysis of Patients With Invasive Lobular Carcinoma (ILC)
5